Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 69

Sort by

Sort Order Select

Meeting Abstracts

1681-P: Metabolomic Signatures of Adiposity in Young Adults with Type 1 Diabetes

DARIA A. IGUDESMAN, ELVIS A. CARNERO, ANNA CASU, ELIZABETH J. MAYER-DAVIS, DAVID M. MAAHS, RICHARD E. PRATLEY, KAREN CORBIN

Diabetes 2024;73(Supplement_1):1681-P

https://doi.org/10.2337/db24-1681-P

Published: 14 June 2024

View article titled, 1681-P: Metabolomic Signatures of Adiposity in Young Adults with Type 1 Diabetes

Meeting Abstracts

17-PUB: Glucagon-Like Peptide 1 Receptor Agonists' Heterogeneous Treatment Effects on Asthma Exacerbations—A Causal Machine-Learning Analysis

TIANSHENG WANG, JOHN B. BUSE, VIRGINIA PATE, RICHARD E. PRATLEY, RICHARD WYSS, KAJSA KVIST, MICHAEL R. KOSOROK, CORINNE KEET, TIL STÜRMER

Diabetes 2024;73(Supplement_1):17-PUB

https://doi.org/10.2337/db24-17-PUB

Published: 14 June 2024

View article titled, 17-PUB: Glucagon-Like Peptide 1 Receptor Agonists' Heterogeneous Treatment Effects on Asthma Exacerbations—A Causal Machine-Learning Analysis

Meeting Abstracts

121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study

RAJAMANNAR THENNATI, VINOD S. BURADE, MUTHUKUMARAN NATARAJAN, PRADEEP SHAHI, RAVISHANKARA NAGARAJA, SUDEEP K. AGRAWAL, THIERRY DUVAUCHELLE, ADOLFO GARCIA-OCANA, GUY A. RUTTER, RICHARD E. PRATLEY, BERNARD THORENS, TINA VILSBØLL

Diabetes 2024;73(Supplement_1):121-OR

https://doi.org/10.2337/db24-121-OR

Published: 14 June 2024

View article titled, 121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study

Meeting Abstracts

144-OR: A Randomized Clinical Trial of Automated Insulin Delivery in Elderly with Type 1 Diabetes

YOGISH C. KUDVA, ROBERT HENDERSON, LAUREN KANAPKA, RUTH S. WEINSTOCK, MICHAEL R. RICKELS, RICHARD E. PRATLEY, NAOMI CHAYTOR, KAMILLE JANESS, DONNA DESJARDINS, VISHWANATH PATTAN, AMY PELECKIS, ANNA CASU, SHAFAQ RAZA RIZVI, SUZAN BZDICK, KERI J. WHITAKER, JORGE L. JO KAMIMOTO, KELLEE MILLER, ROY BECK

Diabetes 2024;73(Supplement_1):144-OR

https://doi.org/10.2337/db24-144-OR

Published: 14 June 2024

View article titled, 144-OR: A Randomized Clinical Trial of Automated Insulin Delivery in Elderly with Type 1 Diabetes

Meeting Abstracts

116-OR: GL0034 (Utreglutide), a Novel GLP-1RA, Increases Liver FGF-21 and Demonstrates Significant Efficacy on Weight Loss, HbA1c, and Triglycerides in db/db Mice

RAJAMANNAR THENNATI, VINOD S. BURADE, MUTHUKUMARAN NATARAJAN, ADOLFO GARCIA-OCANA, GUY A. RUTTER, RICHARD E. PRATLEY, BERNARD THORENS, TINA VILSBØLL

Diabetes 2024;73(Supplement_1):116-OR

https://doi.org/10.2337/db24-116-OR

Published: 14 June 2024

View article titled, 116-OR: GL0034 (Utreglutide), a Novel GLP-1RA, Increases Liver FGF-21 and Demonstrates Significant Efficacy on Weight Loss, HbA1c, and Triglycerides in db/db Mice

Meeting Abstracts

314-OR: A Randomized Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes Mellitus (T1DM)

ANIKA BILAL, ANNA CASU, FANCHAO YI, JUSTINE M. MUCINSKI, GINA MERCOUFFER, DAVID E. KELLEY, RICHARD E. PRATLEY

Diabetes 2024;73(Supplement_1):314-OR

https://doi.org/10.2337/db24-314-OR

Published: 14 June 2024

View article titled, 314-OR: A Randomized Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes Mellitus (T1DM)

Meeting Abstracts

1792-PUB: Predictors of Weight Loss Variability in the COVID-19 Disrupted ACT1ON Diet Pilot in Young Adults with T1D

DARIA IGUDESMAN, ANANTA ADDALA, JAMIE CRANDELL, FRANKLIN R. MUNTIS, DESSI P. ZAHARIEVA, JOAN THOMAS, KAREN CORBIN, ANNA CASU, M. SUE KIRKMAN, MICHAEL R. KOSOROK, RICHARD E. PRATLEY, DAVID M. MAAHS, ELIZABETH J. MAYER-DAVIS

Diabetes 2023;72(Supplement_1):1792-PUB

https://doi.org/10.2337/db23-1792-PUB

Published: 23 June 2023

View article titled, 1792-PUB: Predictors of Weight Loss Variability in the COVID-19 Disrupted ACT1ON Diet Pilot in Young Adults with T1D

Meeting Abstracts

43-LB: Preliminary Evidence of the Validity of a Measure to Assess Diet Acceptability—the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) Study

ANGELICA CRISTELLO SARTEAU, DARIA IGUDESMAN, DAVID M. MAAHS, RICHARD E. PRATLEY, ELIZABETH J. MAYER-DAVIS

Diabetes 2023;72(Supplement_1):43-LB

https://doi.org/10.2337/db23-43-LB

Published: 20 June 2023

View article titled, 43-LB: Preliminary Evidence of the Validity of a Measure to Assess Diet Acceptability—the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) Study

Meeting Abstracts

423-P: Urinary Extracellular Vesicles in African Americans with Chronic Kidney Disease With and Without Type 2 Diabetes Mellitus

TINA K. THETHI, ANIKA BILAL, MATTHEW S. ZAINO, ANTON ILIUK, RICHARD E. PRATLEY, YURY O. NUNEZ LOPEZ

Diabetes 2023;72(Supplement_1):423-P

https://doi.org/10.2337/db23-423-P

Published: 20 June 2023

View article titled, 423-P: Urinary Extracellular Vesicles in African Americans with Chronic Kidney Disease With and Without Type 2 Diabetes Mellitus

Meeting Abstracts

4-OR: Impaired Awareness of Hypoglycemia (IAH) in Older Adults with Type 1 Diabetes in the WISDM Study

ANIKA BILAL, FANCHAO YI, KERI J. WHITAKER, RICHARD E. PRATLEY, ANNA CASU

Diabetes 2023;72(Supplement_1):4-OR

https://doi.org/10.2337/db23-4-OR

Published: 20 June 2023

View article titled, 4-OR: Impaired Awareness of Hypoglycemia (IAH) in Older Adults with Type 1 Diabetes in the WISDM Study

Meeting Abstracts

20-LB: Impact of Optimal Medical Therapy, Insulin Sensitization, and Revascularization Strategies on Soluble Urokinase Plasminogen Activator Receptor and Its Association with Cardiovascular Outcomes—A BARI-2D Ancillary Study

Diabetes 2023;72(Supplement_1):20-LB

https://doi.org/10.2337/db23-20-LB

Published: 20 June 2023

View article titled, 20-LB: Impact of Optimal Medical Therapy, Insulin Sensitization, and Revascularization Strategies on Soluble Urokinase Plasminogen Activator Receptor and Its Association with Cardiovascular Outcomes—A BARI-2D Ancillary Study

Meeting Abstracts

1509-P: Global Metabolomic Profiling and the Pathobiology of Prediabetes and Type 2 Diabetes

DHRUV DUBEY, TUMPA DUTTA, YURY O. NUNEZ LOPEZ, STEPHEN J. GARDELL, RICHARD E. PRATLEY

Diabetes 2023;72(Supplement_1):1509-P

https://doi.org/10.2337/db23-1509-P

Published: 20 June 2023

View article titled, 1509-P: Global Metabolomic Profiling and the Pathobiology of Prediabetes and Type 2 Diabetes

Meeting Abstracts

766-P: Safety and Tolerability of Once-Weekly GL0034 (Utreglutide) in Healthy Individuals—A Multiple Ascending Dose Study

RAJAMANNAR THENNATI, VINOD S. BURADE, MUTHUKUMARAN NATARAJAN, PRADEEP SHAHI, RAVISHANKARA NAGARAJA, SATISH T. PANCHAL, SUDEEP K. AGRAWAL, BERNARD JANDRAIN, THIERRY DUVAUCHELLE, ADOLFO GARCIA-OCANA, GUY A. RUTTER, RICHARD E. PRATLEY, BERNARD THORENS, TINA VILSBØLL

Diabetes 2023;72(Supplement_1):766-P

https://doi.org/10.2337/db23-766-P

Published: 20 June 2023

View article titled, 766-P: Safety and Tolerability of Once-Weekly GL0034 (Utreglutide) in Healthy Individuals—A Multiple Ascending Dose Study

Meeting Abstracts

765-P: A Single Ascending Dose Study of the Novel GLP-1 Receptor Agonist GL0034 (Utreglutide) in Obese Individuals without Diabetes

Diabetes 2023;72(Supplement_1):765-P

https://doi.org/10.2337/db23-765-P

Published: 20 June 2023

View article titled, 765-P: A Single Ascending Dose Study of the Novel GLP-1 Receptor Agonist GL0034 (Utreglutide) in Obese Individuals without Diabetes

Meeting Abstracts

592-P: Living with Type 1 Diabetes (T1DM) as an Older Adult: A Qualitative Study Examining Experiences and Attitudes about Continuous Glucose Monitoring (CGM)

ANNA KAHKOSKA, ANGELICA CRISTELLO, CAMBRAY SMITH, SHARITA R. THOMAS, JOHN BATSIS, ELIZABETH J. MAYER-DAVIS, MICHAEL R. KOSOROK, RICHARD E. PRATLEY, RUTH S. WEINSTOCK, LAURA A. YOUNG, KRISTEN HASSMILLER LICH

Diabetes 2022;71(Supplement_1):592-P

https://doi.org/10.2337/db22-592-P

Published: 01 June 2022

View article titled, 592-P: Living with Type 1 Diabetes (T1DM) as an Older Adult: A Qualitative Study Examining Experiences and Attitudes about Continuous Glucose Monitoring (CGM)

Meeting Abstracts

859-P: Effects of Ertugliflozin on Uric Acid and Gout-Related Outcomes: Post Hoc Analyses from VERTIS CV

VIKAS S. SRIDHAR, FRANCESCO COSENTINO, SAMUEL DAGOGO-JACK, RICHARD E. PRATLEY, ROBERT FREDERICH, MARGARET N. ESSEX, MARIO MALDONADO, CHIH-CHIN LIU, JAMES P. MANCUSO, DAVID CHERNEY

Diabetes 2022;71(Supplement_1):859-P

https://doi.org/10.2337/db22-859-P

Published: 01 June 2022

View article titled, 859-P: Effects of Ertugliflozin on Uric Acid and Gout-Related Outcomes: Post Hoc Analyses from VERTIS CV

Meeting Abstracts

558-P: Effect of Vitamin D Supplementation on Regression to Normal Glucose Regulation from Prediabetes in the D2d Study

DANIEL S. HSIA, JASON P. NELSON, ELLEN VICKERY, NEDA RASOULI, ERIN S. LEBLANC, SUN H. KIM, IRWIN BRODSKY, RICHARD E. PRATLEY, BESS DAWSON-HUGHES, ANASTASSIOS G. PITTAS, D2D RESEARCH GROUP

Diabetes 2022;71(Supplement_1):558-P

https://doi.org/10.2337/db22-558-P

Published: 01 June 2022

View article titled, 558-P: Effect of Vitamin D Supplementation on Regression to Normal Glucose Regulation from Prediabetes in the D2d Study

Meeting Abstracts

32-OR: The Advancing Care for T1D Obesity Network (ACT1ON) Sequential Multiple Assignment Randomized Trial Pilot Re-randomization Results

DARIA IGUDESMAN, JAMIE CRANDELL, TEERANAN POKAPRAKARN, KAREN CORBIN, DESSI P. ZAHARIEVA, ANANTA ADDALA, JOAN THOMAS, ANNA CASU, MICHAEL RIDDELL, RICHARD E. PRATLEY, MICHAEL R. KOSOROK, DAVID M. MAAHS, ELIZABETH J. MAYER-DAVIS

Diabetes 2022;71(Supplement_1):32-OR

https://doi.org/10.2337/db22-32-OR

Published: 01 June 2022

View article titled, 32-OR: The Advancing Care for T1D Obesity Network (ACT1ON) Sequential Multiple Assignment Randomized Trial Pilot Re-randomization Results

Meeting Abstracts

559-P: The Advancing Care for T1D Obesity Network (ACT1ON) Sequential Multiple Assignment Randomized Trial Pilot Results for Effect on Weight and Glycemia

Diabetes 2022;71(Supplement_1):559-P

https://doi.org/10.2337/db22-559-P

Published: 01 June 2022

View article titled, 559-P: The Advancing Care for T1D Obesity Network (ACT1ON) Sequential Multiple Assignment Randomized Trial Pilot Results for Effect on Weight and Glycemia

Meeting Abstracts

865-P: Long-Term Ertugliflozin Treatment and Incidence of Hypoglycemia: Analyses from VERTIS CV

SAMUEL DAGOGO-JACK, CHRISTOPHER P. CANNON, DAVID CHERNEY, FRANCESCO COSENTINO, DARREN K. MCGUIRE, JIE LIU, CHIH-CHIN LIU, ROBERT FREDERICH, JAMES P. MANCUSO, RICHARD E. PRATLEY

Diabetes 2022;71(Supplement_1):865-P

https://doi.org/10.2337/db22-865-P

Published: 01 June 2022

View article titled, 865-P: Long-Term Ertugliflozin Treatment and Incidence of Hypoglycemia: Analyses from VERTIS CV

NARROW

1681-P: Metabolomic Signatures of Adiposity in Young Adults with Type 1 Diabetes

17-PUB: Glucagon-Like Peptide 1 Receptor Agonists' Heterogeneous Treatment Effects on Asthma Exacerbations—A Causal Machine-Learning Analysis

121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study

144-OR: A Randomized Clinical Trial of Automated Insulin Delivery in Elderly with Type 1 Diabetes

116-OR: GL0034 (Utreglutide), a Novel GLP-1RA, Increases Liver FGF-21 and Demonstrates Significant Efficacy on Weight Loss, HbA1c, and Triglycerides in db/db Mice

314-OR: A Randomized Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes Mellitus (T1DM)

1792-PUB: Predictors of Weight Loss Variability in the COVID-19 Disrupted ACT1ON Diet Pilot in Young Adults with T1D

43-LB: Preliminary Evidence of the Validity of a Measure to Assess Diet Acceptability—the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) Study

423-P: Urinary Extracellular Vesicles in African Americans with Chronic Kidney Disease With and Without Type 2 Diabetes Mellitus

4-OR: Impaired Awareness of Hypoglycemia (IAH) in Older Adults with Type 1 Diabetes in the WISDM Study

20-LB: Impact of Optimal Medical Therapy, Insulin Sensitization, and Revascularization Strategies on Soluble Urokinase Plasminogen Activator Receptor and Its Association with Cardiovascular Outcomes—A BARI-2D Ancillary Study

1509-P: Global Metabolomic Profiling and the Pathobiology of Prediabetes and Type 2 Diabetes

766-P: Safety and Tolerability of Once-Weekly GL0034 (Utreglutide) in Healthy Individuals—A Multiple Ascending Dose Study

765-P: A Single Ascending Dose Study of the Novel GLP-1 Receptor Agonist GL0034 (Utreglutide) in Obese Individuals without Diabetes

592-P: Living with Type 1 Diabetes (T1DM) as an Older Adult: A Qualitative Study Examining Experiences and Attitudes about Continuous Glucose Monitoring (CGM)

859-P: Effects of Ertugliflozin on Uric Acid and Gout-Related Outcomes: Post Hoc Analyses from VERTIS CV

558-P: Effect of Vitamin D Supplementation on Regression to Normal Glucose Regulation from Prediabetes in the D2d Study

32-OR: The Advancing Care for T1D Obesity Network (ACT1ON) Sequential Multiple Assignment Randomized Trial Pilot Re-randomization Results

559-P: The Advancing Care for T1D Obesity Network (ACT1ON) Sequential Multiple Assignment Randomized Trial Pilot Results for Effect on Weight and Glycemia

865-P: Long-Term Ertugliflozin Treatment and Incidence of Hypoglycemia: Analyses from VERTIS CV

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only